Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients.
Sugita K, Steer CA, Martinez-Gonzalez I, Altunbulakli C, Morita H, Castro-Giner F, Kubo T, Wawrzyniak P, Rückert B, Sudo K, Nakae S, Matsumoto K, O'Mahony L, Akdis M, Takei F, Akdis CA.
Sugita K, et al.
J Allergy Clin Immunol. 2018 Jan;141(1):300-310.e11. doi: 10.1016/j.jaci.2017.02.038. Epub 2017 Apr 6.
J Allergy Clin Immunol. 2018.
PMID: 28392332